National & International Awards

• Pioneer in Submandibular Salivary Gland Transfer — India (head & neck oncology innovation)
• Principal Investigator — Oesophageal & Lung Cancer Clinical Trials
• Successfully removed a 7.5 kg cancerous tumour from a teenage patient — nationally reported case

Professional Memberships

• Indian Society of Surgical Oncologists
• Indian Society of Oncology
• International Society for Diseases of the Oesophagus
• International Society for Lung Cancer
• Association of Head & Neck Surgeons

Published Papers (Selected)

• Kaler A, Mistry R, et al. 'Mini Review: Molecular Pathology of Personalized Medicine in Cancer Susceptibility Syndromes.' International Journal of Molecular and Immuno Oncology. 2023;8:1–8.
• Fatima S, Shaikh I, Mistry R, Kaler A. 'Long-term Efficacy of Osimertinib in De Novo Exon 19 Deletion with T790M.' International Journal of Molecular and Immuno Oncology. 2023;9:1–4.
• Kaler A, Mistry R, et al. 'Mutational Analysis of EGFR Mutations in Non-Small Cell Lung Carcinoma — An Indian Perspective of 212 Patients.' International Journal of Environmental Research & Public Health. 2022;20:758.
• 80+ publications total — full bibliography available on request.

Ongoing Research & Clinical Interests

• EGFR mutations in lung cancer in India
• Thoraco-laparoscopic oesophagectomy outcomes
• PET-CT in lung cancer staging
• Pulmonary metastasectomy indications

A patient with locally advanced oesophageal cancer deemed inoperable elsewhere underwent successful thoraco-laparoscopic oesophagectomy under Dr. Mistry's care at Kokilaben Hospital Mumbai, achieving complete R0 resection and disease-free survival at 5-year follow-up.

A young patient with a massive 7.5 kg thoracic mass — unprecedented in size — underwent successful surgical removal under Dr. Mistry in a landmark case that received national media attention and advanced the field of thoracic surgical oncology in India.

• Unmatched Expertise: Patients describe Dr. Mistry as the definitive authority in thoracic and head & neck oncology surgery in India — sought out when other surgeons have declined to operate.
• Compassionate Resilience: Families of patients with advanced cancer praise him for continuing to seek surgical solutions and never abandoning patients with complex or high-risk cases.
• Pioneering Innovation: Described by peers and patients as a surgeon who consistently advances surgical technique — his submandibular salivary gland transfer is now widely adopted.

Patient-Centred Care

Dr. Mistry takes an evidence-based, multidisciplinary approach to surgical oncology. He is known for holding frank, honest discussions about surgical risks, expected outcomes, and quality-of-life considerations — and for working relentlessly to find surgical solutions for patients who have been declined elsewhere. He participates actively in tumour board discussions at Kokilaben Hospital.

Technology & Innovation

Dr. Mistry employs VATS (Video-Assisted Thoracoscopic Surgery), robotic thoracic surgery, thoraco-laparoscopic oesophagectomy, and minimally invasive pulmonary resection. He is a principal investigator in clinical trials evaluating novel agents in oesophageal and lung cancers. His fellowship under Prof. H. Akiyama in Tokyo — one of the world's pioneers of oesophageal surgery — grounds his oesophagectomy technique in globally current standards.

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.

Language Support

English and Hindi are spoken; Cancer Rounds provides certified interpreters for all major international languages on request.

Visa & Travel Assistance

Cancer Rounds provides medical visa invitation letters, airport transfers, and local accommodation coordination for international patients seeking treatment from Dr. Rajesh Mistry.

Virtual Consultations

Pre-travel video consultations are available through Cancer Rounds, allowing patients to share medical records and discuss treatment plans with Dr. Rajesh Mistry before travelling to India.